生物制藥公司 的英文怎麼說

中文拼音 [shēngwùzhìyàogōngsī]
生物制藥公司 英文
biopharmaceutical company
  • 生 : Ⅰ動詞1 （生育; 生殖） give birth to; bear 2 （出生） be born 3 （生長） grow 4 （生存; 活） live;...
  • 物 : 名詞1 （東西） thing; matter; object 2 （指自己以外的人或與己相對的環境） other people; the outsi...
  • 制 : Ⅰ動詞1 （製造） make; manufacture 2 （擬訂; 規定） draw up; establish 3 （用強力約束; 限定; 管束...
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 公 : Ⅰ形容詞1 （屬于國家或集體的） state owned; collective; public 2 （共同的;大家承認的） common; gen...
  • 司 : Ⅰ動詞（主持; 操作; 經營） take charge of; attend to; manage Ⅱ名詞1 （部一級機關里的一個部門） dep...
  • 生物 : living things; living beings; organisms; bios （pl bioi bioses）; biont; thing; life生物材料 biol...
  1. In this review, up - to - date information on biocatalysis research, development and application together with some viewpoints of experts from world famous chemical or pharmaceutical companies were collected and summarized, with the aim to benefit chinese researchers in the field of industrial biocatalysis

    綜述了一些著名的國際化工或制藥公司最近在生物催化技術研發和應用方面的動態信息以及相關技術的一些評論，以便我國從事工業生物催化工作的相關人士能從中獲得有益啟示。
  2. In the past 21 years dalian office finished more than 120 projects all over north - east in the field of microelectronic, optical fiber and cable, lcd, biological and pharmaceutical, mechanic, assembly, steel, ship manufacturing and domestic buildings. some of the projects got the prize from national or provincial construction department. below are the reference projects dalian office finished these years : dalian dongfu lcd co., ltd, dalian haire industry park, guangyang bearings dalian co., ltd, konica dalian co., ltd, canon dalian office appliance co., ltd, pacifica electronics co., ltd, photoelectron dalian co., ltd, hyundai electronics dalian, rhi dalian co., ltd, yuanda pharmaceutical co., ltd, siemens vdo auto electronics changchun, toyota tianjin precise products co., ltd 6000, toyota zhangjiagang technology co., ltd, shenyang sico semiconductor co., ltd, dalian dongxian and dalian orient precise products co., ltd. dalian office will carry the principle make best design, provide satisfying service to provide our best service to the clients

    Edri大連分院成立至今完成120多項工程設計監理及工程總承包項目，其中多個項目工程設計獲得國家和部省級科技進步獎，先後完成了大連東福彩色液晶顯示器工程大連海爾工業園光洋軸承大連有限公司柯尼卡大連有限公司佳能辦公設備大連有限公司太平洋電子有限公司光電子大連有限公司現代電子大連有限公司奧鎂大連有限公司，大連高新生物制藥有限公司大連保稅區國際車城遠大制藥有限公司西門子威迪歐汽車電子長春有限公司豐田合成天津精密製品有限公司豐田合成張家港科技有限公司，沈陽科希-硅技半導體技術第一有限公司大連東顯電子有限公司大連東方精工有限公司等一大批高科技產業園區設計項目，並且進行全程質量跟蹤服務，在業內樹立起edri大連分院良好口碑，贏得了客戶廣泛好評，為我院在東北地區的發展做出了自己的貢獻。
  3. I do not like the hype and some other salesmanship of big pharma and bio - tech companies, but this industry has made enormous contributions to raising world health

    我不喜歡大型制藥公司和生物技術公司的天花亂墜的廣告以及其它五花八門的推銷術，但是制藥產業已經為提高世界健康水平作出了巨大的貢獻。
  4. Dalian tianwei pharmaceutical co., ltd. is one of the first hi - tech enterprises settled down in dalian d - d port

    大連天維藥業股份有限公司位於大連雙d港生物制藥園。
  5. Hdb s mission is to provide advanced solutions for drug discovery and assist pharmaceutical and biotech companies in their search for innovative, effective, and safe drug candidates at a controlled cost

    公司還成功地與國內外多家知名制藥及生物技術公司建立了戰略合作夥伴關系。提供新藥研發中具有創新性和高效低成本的服務。
  6. During the visit, margaret had fruitful meetings with leading medical device manufacturers like mindray and precision medical plastics. she also had the chance to meet with biotech and pharmaceutical companies such as xiangxue, gena, surexam, innogent and sibiono to explore business opportunities together

    在此行中還與香雪、捷納、益善、依諾金、賽百諾等生物制藥公司進行了討論，共同探討他們在英國的商業機會。
  7. The market occupation of retapase project has been over appraised and the market orientation is based on self - reference while less weight has been put on market survey ; the project fund comes inadequately from self - raised resources or by transferring the techniques. in the organization framework of the project, the conventional linear system is adopted, which inhibit imbibing the wisdom of majority ; on personnel management, the r & d professionals have been weighed much more against the management professionals and little effort has been put on building the professionals reservoir, while the personnel incentive tactics are not conducive to the long benefit of the project in addition, the cost management is maldeveloped and the project progress controlling has been neglected

    瑞特普酶項目屬生物制藥項目，本文對fdzj公司瑞特普酶項目的管理現狀進行了詳細分析，具體有待改進地方有：市場份額估計過高，市場定位本位化，市場調查注重不足；項目融資僅採用自籌資金及科技成果轉讓的方式；項目組織結構為傳統的直線制，不利於集思廣義，人員配備重研發人才，輕管理人才，人才儲備工作欠缺，人員激勵策略與項目長遠利益不銜接；成本管理欠缺，忽視進度管理等。
  8. We are a professional translation company, relate to scopes include : accountant, mechanics, electronics, chemical, bio - pharmaceuticals, motorcar and other fields, have experience in translation, handle with more than 20 kinds of different languages, such as : english, french, german, russian, arabic, danish, dutch, portuguese, japanese, turkish, spanish, italian, korea, polish, finnish, czech, norwegian, swedish, vietnamese ， greece ， hungarian ； have experts on proofread and layout co - workers, competitive price, high quality and consummate service

    我公司是專業從事翻譯服務的機構，涉及的領域包括：會計、機械、工程、電子、化工、生物制藥、汽車等方面，具有豐富的翻譯經驗，現已做過的語種有二十種：英、法、德、俄、阿拉伯、丹麥、荷蘭、葡語、日語、土耳其、西班牙、義大利、韓語、波蘭語、芬蘭語、捷克語、挪威語、瑞典語、越南語、希臘語、匈牙種語；有專業的校對和排版人員，低廉的價格和好的質量及優質的服務
  9. Acoording to company valuation theory, based on ananlysis and comparison of present company valuation model and valuation technology, combining characteristics of biopharmacy company of high technology, high risk, high profits, i take sichuan dikang science and technology pharmacy, a biomedical listing company for dcfm model value ' s valuation. through analysing dikang ' s past achievements and value - driving business, i made

    本文根據公司價值的有關理論，對目前運用的公司價值評估模型和評估技術的進行分析和比較基礎上，結合生物制藥上市公司高技術、高風險、高收益等高新技術企業特點，選擇貼現現金流模型對物制藥上市公司? ?四川迪康科技藥業股份有限公司的價值進行評估。
  10. Dalian asia space pharmaceutical co., ltd. makes use of the first industrial base of “ bio - missile ” ( monoclonal antibody ) in china to research, develop, manufacture and sell monoclonal antibody drugs contributing to promoting chinese bio - pharmaceutical industry and people ' s medical treatment and health

    大連亞維藥業有限公司的目標是依託中國第一個「生物導彈」 （單克隆抗體）研製生產基地，大規模研究、開發、生產和銷售單克隆抗體治療用藥品，為提高中國生物制藥產業水平和人民醫療健康水平做出貢獻。
  11. Pharmaceutical companies have begun to inspect the first systems for performing bioassays produced by surface logix ' s soft lithography

    表面羅技公司使用軟微影術來製作生物測定設備，制藥公司也開始檢視這些初期的系統了。
  12. Examples would include professors leaving the universities of wisconsin, iowa state and purdue and forming companies in the new bio - genetics areas, performing gene splitting, and producing new products in animal and plant life, and pharmaceuticals as well

    成功的例子包括離開威斯康星大學、愛荷華州立大學和普渡大學的教授們成立了生物技術公司，進行基因分離，新動植物產品的生產，以及制藥等。
  13. The initial application for this technology is expected to involve pharmaceutical companies, which could use the biological chips to test potential drugs in the lab more quickly and accurately

    這項技術最初設想是在制藥公司應用，用這種生物晶元來在實驗室中更及時更精確的檢測潛在的藥物。
  14. A few years passed, what is the performance of the companies which have invested the biopharmacy industry

    幾年過去了，這些投資生物制藥的公司經營業績到底如何
  15. However, some listing corporations do not achieve outstanding achievements. biopharmacy companies are faced with both huge developing potential and risks

    生物制藥上市公司企業面臨著巨大的發展潛力，同時也承受著極大的風險。
  16. Chapter four is the emphasis of this dissertation, it focuses on the result of the performance evaluation of the biopharmacy public companies

    第四章是本文的重點，主要介紹本文的實證結果，以及生物制藥上市公司經營業績評價結果。
  17. Since 1999, many companies in our country started to go into the biopharmacy field by all kinds of forms, and invested the biopharmacy industry during the two years of 1997 - 1998

    自1992年起，我國許多公司就開始以各種形式介入生物制藥領域，並在1997 - 1998兩年，形成了轟轟烈烈的投資生物制藥的高潮。
  18. In this dissertation, i will select the excellent public companies which represent the biopharmacy industry as the study target, use the factor analysis method based on finance measures to evaluate the public companies of the biopharmacy industry

    本文將把代表生物制藥行業的優秀上市公司作為研究對象，採用以財務指標為基礎的因子分析方法來綜合評價生物制藥上市公司的經營業績。
  19. The topic of the first chapter is mainly to introduce the concept and the character of the biopharmacy, the development outline of the biopharmacy industry in our civil country and outside of our country and the public companies outline of the biopharmacy industry in our country

    本文共分五章。第一章主要介紹生物制藥的概念和特點、國內外生物制藥行業發展概況以及我國生物制藥上市公司概況。
  20. The total contract research organisation ( cro ) market is expected to reach $ 24bn ( ? 18bn ) by 2010 as biopharma companies ' spending on outsourcing serices continues to soar, new research reeals

    一項新的研究表明，由於生物制藥公司外包服務開銷持續高漲，合同研究組織（ cro ）總的市場份額到2010年將達250億美元（ 180億歐元） 。
分享友人
分享到 Line

分享到臉書